Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
03 Jun 2024
Historique:
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 5 6 2024
Statut: epublish

Résumé

Recent changes in China's social medical insurance reimbursement policy have impacted the financial burden of patients with phenylketonuria (PKU) for special foods. However, whether this policy change is associated with their blood phenylalanine (PHE) concentration is unclear. To investigate the association between the reimbursement policy and blood PHE concentration in patients with PKU. This cohort study measured the blood PHE concentrations of 167 patients with PKU across 4 newborn screening centers in China from January 2018 to December 2021. The reimbursement policy for special foods for patients with PKU at 2 centers was canceled in 2019 and restored from 2020 onwards. In contrast, the other 2 centers consistently implemented the policy. Data were analyzed from September 10 to December 6, 2023. The implementation and cancelation of the reimbursement policy for special foods of patients with PKU. The blood PHE concentration was regularly measured from 2018 to 2021. A 1-sided Z test was used to compare the mean of the blood PHE concentration between different years. Among 167 patients with PKU (mean [SD] age, 84.4 [48.3] months; 87 males [52.1%]), a total of 4285 measurements of their blood PHE concentration were collected from 2018 to 2021. For patients at the center that canceled the reimbursement policy in 2019, the mean (SD) of the blood PHE concentrations in 2019 was 5.95 (5.73) mg/dL, significantly higher than 4.84 (4.11) mg/dL in 2018 (P < .001), 5.06 (5.21) mg/dL in 2020 (P = .006), and 4.77 (4.04) mg/dL in 2021 (P < .001). Similarly, for patients at the other center that canceled the policy in 2019, the mean (SD) of the blood PHE concentrations in 2019 was 5.95 (3.43) mg/dL, significantly higher than 5.34 (3.45) mg/dL in 2018 (P = .03), 5.13 (3.15) mg/dL in 2020 (P = .003), and 5.39 (3.46) mg/dL in 2021 (P = .03). On the contrary, no significant difference was observed between any of the years for patients at the 2 centers that consistently implemented the policy. In this cohort study of patients with PKU from multiple centers, the implementation of the reimbursement policy for special foods was associated with controlling the blood PHE concentration. Special foods expenditure for patients with PKU should be included in the scope of long-term social medical insurance reimbursement.

Identifiants

pubmed: 38837161
pii: 2819561
doi: 10.1001/jamanetworkopen.2024.12886
doi:

Substances chimiques

Phenylalanine 47E5O17Y3R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2412886

Auteurs

Bo Wang (B)

College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Medical Genetics Center, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, PR China.

Yanzhi Xia (Y)

College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.

Mingyue Cheng (M)

College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.

Huili Luo (H)

Department of Medical Laboratory Technology, Shiyan Maternal and Child Health Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, Hubei, PR China.

Luxi Xue (L)

Child Health Department, Maternal and Child Health Hospital of Jingzhou, Jingzhou, Hubei, PR China.

Anyue Gong (A)

Newborn Disease Screening Laboratory, Xiangyang Maternal and Child Health Hospital, Xiangyang, Hubei, PR China.

Xu Liu (X)

Medical Genetics Center, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, PR China.

Gaoqi Liao (G)

Medical Genetics Center, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, PR China.

Jieping Song (J)

Medical Genetics Center, Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, PR China.

Kang Ning (K)

College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH